financetom
Business
financetom
/
Business
/
US Appeals Court Blocks Transportation Department Rule on Upfront Airline Fee Disclosure
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US Appeals Court Blocks Transportation Department Rule on Upfront Airline Fee Disclosure
Jul 30, 2024 8:47 AM

11:27 AM EDT, 07/30/2024 (MT Newswires) -- US Court of Appeals for the Fifth Circuit granted a motion for the stay of a new rule by the US Transportation Department on upfront disclosure of airline fees pending a review of the regulation.

Delta Air Lines ( DAL ) , United Airlines (UAL), American Airlines ( AAL ) , JetBlue Airways ( JBLU ) , Alaska Airlines (ALK), Hawaiian Airlines (HA), the trade group Airlines for America, the National Air Carrier Association and the International Air Transport Association were among the airlines and groups that sued to block the rule.

The rule, which mandates airlines and ticket agents to disclose service fees along with the airfare, "likely exceeds DOT's authority and will irreparably harm airlines," according to the ruling by a three-judge panel.

The ruling also expedited the petition to the next available oral argument panel.

"DOT will continue defending our rule that protects consumers from surprise fees that can unexpectedly jack up the price of air travel," a department spokesperson told MT Newswires in an email. "Nothing in the court's decision prevents airlines from voluntarily complying with this common sense rule that simply requires them to keep their customers fully informed when buying a plane ticket."

United and American referred requests for comment to Airlines for America. Delta Air Lines ( DAL ), JetBlue Airways ( JBLU ), Alaska Airlines, Hawaiian Airlines, National Air Carrier Association and International Air Transport Association did not immediately respond to requests for comment.

Price: 43.71, Change: +0.67, Percent Change: +1.57

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved